SMAD3 and chronic myelogenous leukemia, BCR-ABL1 positive: Once again, future work should determine how Smad3 interacts with Foxo3a, how phospho-Smad3–Ser208 regulates Foxo3a's activity and whether this interaction regulates the maintenance of CML stemness in vivo.